Trial
NCT06153186
Flunarizine for Treatment Resistant Absence Epilepsy
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of British Columbia
Collaborators
—
Condition
Childhood Absence Epilepsy
Intervention
Flunarizine Hydrochloride
Why stopped
The enrollment wasn't as predicted. We didn't have enough numbers to show statistical significance.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-12-01